495 related articles for article (PubMed ID: 24754519)
1. Magnetic nanoparticles as contrast agents in biomedical imaging: recent advances in iron- and manganese-based magnetic nanoparticles.
Felton C; Karmakar A; Gartia Y; Ramidi P; Biris AS; Ghosh A
Drug Metab Rev; 2014 May; 46(2):142-54. PubMed ID: 24754519
[TBL] [Abstract][Full Text] [Related]
2. Paramagnetic nanoparticle T1 and T2 MRI contrast agents.
Xu W; Kattel K; Park JY; Chang Y; Kim TJ; Lee GH
Phys Chem Chem Phys; 2012 Oct; 14(37):12687-700. PubMed ID: 22885983
[TBL] [Abstract][Full Text] [Related]
3. Iron oxide nanoparticles - In vivo/in vitro biomedical applications and in silico studies.
Nedyalkova M; Donkova B; Romanova J; Tzvetkov G; Madurga S; Simeonov V
Adv Colloid Interface Sci; 2017 Nov; 249():192-212. PubMed ID: 28499604
[TBL] [Abstract][Full Text] [Related]
4. L-DOPA-Coated Manganese Oxide Nanoparticles as Dual MRI Contrast Agents and Drug-Delivery Vehicles.
McDonagh BH; Singh G; Hak S; Bandyopadhyay S; Augestad IL; Peddis D; Sandvig I; Sandvig A; Glomm WR
Small; 2016 Jan; 12(3):301-6. PubMed ID: 26619158
[TBL] [Abstract][Full Text] [Related]
5. Hybrid, metal oxide-peptide amphiphile micelles for molecular magnetic resonance imaging of atherosclerosis.
Poon C; Gallo J; Joo J; Chang T; Bañobre-López M; Chung EJ
J Nanobiotechnology; 2018 Nov; 16(1):92. PubMed ID: 30442135
[TBL] [Abstract][Full Text] [Related]
6. Design of iron oxide-based nanoparticles for MRI and magnetic hyperthermia.
Blanco-Andujar C; Walter A; Cotin G; Bordeianu C; Mertz D; Felder-Flesch D; Begin-Colin S
Nanomedicine (Lond); 2016 Jul; 11(14):1889-910. PubMed ID: 27389703
[TBL] [Abstract][Full Text] [Related]
7. In Vivo Dual-Modality Fluorescence and Magnetic Resonance Imaging-Guided Lymph Node Mapping with Good Biocompatibility Manganese Oxide Nanoparticles.
Zhan Y; Zhan W; Li H; Xu X; Cao X; Zhu S; Liang J; Chen X
Molecules; 2017 Dec; 22(12):. PubMed ID: 29231865
[TBL] [Abstract][Full Text] [Related]
8. One-pot preparation of hydrophilic manganese oxide nanoparticles as T
Li J; Wu C; Hou P; Zhang M; Xu K
Biosens Bioelectron; 2018 Apr; 102():1-8. PubMed ID: 29101783
[TBL] [Abstract][Full Text] [Related]
9. Long-circulating PEGylated manganese ferrite nanoparticles for MRI-based molecular imaging.
Pernia Leal M; Rivera-Fernández S; Franco JM; Pozo D; de la Fuente JM; García-Martín ML
Nanoscale; 2015 Feb; 7(5):2050-9. PubMed ID: 25554363
[TBL] [Abstract][Full Text] [Related]
10. Manganese Oxide Nanoparticles As MRI Contrast Agents In Tumor Multimodal Imaging And Therapy.
Cai X; Zhu Q; Zeng Y; Zeng Q; Chen X; Zhan Y
Int J Nanomedicine; 2019; 14():8321-8344. PubMed ID: 31695370
[TBL] [Abstract][Full Text] [Related]
11. Photo-fluorescent and magnetic properties of iron oxide nanoparticles for biomedical applications.
Shi D; Sadat ME; Dunn AW; Mast DB
Nanoscale; 2015 May; 7(18):8209-32. PubMed ID: 25899408
[TBL] [Abstract][Full Text] [Related]
12. Magnetic nanoparticles for precision oncology: theranostic magnetic iron oxide nanoparticles for image-guided and targeted cancer therapy.
Zhu L; Zhou Z; Mao H; Yang L
Nanomedicine (Lond); 2017 Jan; 12(1):73-87. PubMed ID: 27876448
[TBL] [Abstract][Full Text] [Related]
13. An update on clinical applications of magnetic nanoparticles for increasing the resolution of magnetic resonance imaging.
Zeinali Sehrig F; Majidi S; Asvadi S; Hsanzadeh A; Rasta SH; Emamverdy M; Akbarzadeh J; Jahangiri S; Farahkhiz S; Akbarzadeh A
Artif Cells Nanomed Biotechnol; 2016 Nov; 44(7):1583-8. PubMed ID: 26584684
[TBL] [Abstract][Full Text] [Related]
14. Urchin-shaped manganese oxide nanoparticles as pH-responsive activatable T1 contrast agents for magnetic resonance imaging.
Kim T; Cho EJ; Chae Y; Kim M; Oh A; Jin J; Lee ES; Baik H; Haam S; Suh JS; Huh YM; Lee K
Angew Chem Int Ed Engl; 2011 Nov; 50(45):10589-93. PubMed ID: 21928456
[No Abstract] [Full Text] [Related]
15. Iron oxide/manganese oxide co-loaded hybrid nanogels as pH-responsive magnetic resonance contrast agents.
Wang X; Niu D; Wu Q; Bao S; Su T; Liu X; Zhang S; Wang Q
Biomaterials; 2015; 53():349-57. PubMed ID: 25890733
[TBL] [Abstract][Full Text] [Related]
16. Targeted dual-contrast T1- and T2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide nanoparticles.
Yang H; Zhuang Y; Sun Y; Dai A; Shi X; Wu D; Li F; Hu H; Yang S
Biomaterials; 2011 Jul; 32(20):4584-93. PubMed ID: 21458063
[TBL] [Abstract][Full Text] [Related]
17. Iron oxide nanoparticle surface decorated with cRGD peptides for magnetic resonance imaging of brain tumors.
Richard S; Boucher M; Lalatonne Y; Mériaux S; Motte L
Biochim Biophys Acta Gen Subj; 2017 Jun; 1861(6):1515-1520. PubMed ID: 28017683
[TBL] [Abstract][Full Text] [Related]
18. Engineered core-shell magnetic nanoparticle for MR dual-modal tracking and safe magnetic manipulation of ependymal cells in live rodents.
Peng YK; Lui CNP; Chen YW; Chou SW; Chou PT; Yung KKL; Tsang SCE
Nanotechnology; 2018 Jan; 29(1):015102. PubMed ID: 29205171
[TBL] [Abstract][Full Text] [Related]
19. Contrast Agents Based on Iron Oxide Nanoparticles for Clinical Magnetic Resonance Imaging.
Abakumov MA; Ternovoi SK; Mazhuga AG; Chekhonin VP; Demikhov EI; Pistrak AG; Konstantinov MV; Dmitriev DM; Myshkinis BY
Bull Exp Biol Med; 2019 Jun; 167(2):272-274. PubMed ID: 31243671
[TBL] [Abstract][Full Text] [Related]
20. Fabrication of MnxFe1-xO colloidal solid solution as a dual magnetic-resonance-contrast agent.
Choi D; Han A; Park JP; Kim JK; Lee JH; Kim TH; Kim SW
Small; 2009 Mar; 5(5):571-3. PubMed ID: 19089842
[No Abstract] [Full Text] [Related]
[Next] [New Search]